Gene · 6080
Papers2,015
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,015
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclin E in normal physiology and disease states. | Trends Cell Biol | 2021 | 34052101 | PubTator, text mining | PubMed |
| Mitochondrial Targeting Domain Homologs Induce Necrotic Cell Death Via Mitochondrial and Endoplasmic Reticulum Disruption. | J Microbiol Biotechnol | 2021 | 34024890 | PubTator, text mining | PubMed |
| Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases. | Ageing Res Rev | 2021 | 34023421 | PubTator, text mining | PubMed |
| On-chip perivascular niche supporting stemness of patient-derived glioma cells in a serum-free, flowable culture. | Lab Chip | 2021 | 33969368 | PubTator, text mining | PubMed |
| Molecular characterization of canine adenovirus type 2 in dogs from India. | Virusdisease | 2021 | 33969151 | PubTator, text mining | PubMed |
| Toward an Understanding of the Structural and Mechanistic Aspects of Protein-Protein Interactions in 2-Oxoacid Dehydrogenase Complexes. | Life (Basel) | 2021 | 33946784 | PubTator, text mining | PubMed |
| Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19. | Front Mol Biosci | 2021 | 33937326 | PubTator, text mining | PubMed |
| Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. | Biochim Biophys Acta Rev Cancer | 2021 | 33932560 | PubTator, text mining | PubMed |
| Targeting Ubiquitin-Proteasome System With Copper Complexes for Cancer Therapy. | Front Mol Biosci | 2021 | 33928122 | PubTator, text mining | PubMed |
| Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy. | Cancers (Basel) | 2021 | 33919679 | PubTator, text mining | PubMed |
| Coxsackievirus B3-Its Potential as an Oncolytic Virus. | Viruses | 2021 | 33919076 | PubTator, text mining | PubMed |
| Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model. | Cancer Immunol Immunother | 2021 | 33903973 | PubTator, text mining | PubMed |
| Is immunotherapy in the future of therapeutic management of sarcomas? | J Transl Med | 2021 | 33902630 | PubTator, text mining | PubMed |
| Ascorbate-dependent and ascorbate-independent Mn porphyrin cytotoxicity: anticancer activity of Mn porphyrin-based SOD mimics through ascorbate-dependent and -independent routes. | Redox Rep | 2021 | 33902399 | PubTator, text mining | PubMed |
| Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression. | PLoS One | 2021 | 33886686 | PubTator, text mining | PubMed |
| Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology. | Proc Natl Acad Sci U S A | 2021 | 33879606 | PubTator, text mining | PubMed |
| Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer. | Cancer Manag Res | 2021 | 33854378 | PubTator, text mining | PubMed |
| The infectivity of progeny adenovirus in the presence of neutralizing antibody. | J Gen Virol | 2021 | 33843575 | PubTator, text mining | PubMed |
| Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions. | Cancers (Basel) | 2021 | 33803211 | PubTator, text mining | PubMed |
| The Current Status of Gene Therapy for the Treatment of Cancer. | Biologics | 2021 | 33776419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6080/papers?page=17